More Inconclusive Results from PFO-Closure Trials
Clinical Trials Tuesday, April 2nd, 2013Journal Watch Cardiology: March 20, 2013
Patent foramen ovale (PFO) is more prevalent in patients with cryptogenic stroke than in the general population, but can correction of the PFO reduce stroke incidence? Findings from the CLOSURE I trial of the STARFlex PFO-closure device after cryptogenic stroke showed no significant reduction in the rate of recurrent stroke compared with medical therapy (JW Neurol Mar 14 2012). Now, results are available from two randomized trials of another device (the Amplatzer PFO Occluder). Read more
